BR112016028890A2 - derivado de macrolídeo de polieno - Google Patents

derivado de macrolídeo de polieno

Info

Publication number
BR112016028890A2
BR112016028890A2 BR112016028890A BR112016028890A BR112016028890A2 BR 112016028890 A2 BR112016028890 A2 BR 112016028890A2 BR 112016028890 A BR112016028890 A BR 112016028890A BR 112016028890 A BR112016028890 A BR 112016028890A BR 112016028890 A2 BR112016028890 A2 BR 112016028890A2
Authority
BR
Brazil
Prior art keywords
polyene macrolide
macrolide derivative
present
derivative
compound
Prior art date
Application number
BR112016028890A
Other languages
English (en)
Other versions
BR112016028890A8 (pt
Inventor
Sugimoto Hideki
Miyazaki Keisuke
Takaya Kenji
Fujitani Manabu
Suzuki Naoyuki
Ohara Takafumi
OGATA Yuki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of BR112016028890A2 publication Critical patent/BR112016028890A2/pt
Publication of BR112016028890A8 publication Critical patent/BR112016028890A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

a presente invenção refere-se ao derivado de anfotericina b, em que cada símbolo é definido na descrição. o composto da presente invenção possui a estrutura de uréia, estrutura cíclica, hidroxialquila ou monoalquilcarbamoíla substituída na 16a posição (x). o composto da presente invenção possui atividade antifúngica.
BR112016028890A 2014-06-12 2015-06-12 composto derivado de macrolídeo de polieno, composição farmacêutica compreendendo o referido composto e processo para a preparação do mesmo BR112016028890A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014121341 2014-06-12
PCT/JP2015/066976 WO2015190587A1 (ja) 2014-06-12 2015-06-12 ポリエンマクロライド誘導体

Publications (2)

Publication Number Publication Date
BR112016028890A2 true BR112016028890A2 (pt) 2017-08-22
BR112016028890A8 BR112016028890A8 (pt) 2021-03-23

Family

ID=54833670

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016028890A BR112016028890A8 (pt) 2014-06-12 2015-06-12 composto derivado de macrolídeo de polieno, composição farmacêutica compreendendo o referido composto e processo para a preparação do mesmo

Country Status (16)

Country Link
US (2) US10246478B2 (pt)
EP (1) EP3156410A4 (pt)
JP (1) JP6601818B2 (pt)
KR (1) KR102106765B1 (pt)
CN (1) CN106414473B (pt)
AU (1) AU2015272398B2 (pt)
BR (1) BR112016028890A8 (pt)
CA (1) CA2951516C (pt)
EA (1) EA037093B1 (pt)
IL (1) IL249430B (pt)
MA (1) MA39568A1 (pt)
MX (1) MX2016015455A (pt)
PH (1) PH12016502357A1 (pt)
SG (1) SG11201610162XA (pt)
TW (1) TWI702223B (pt)
WO (1) WO2015190587A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6755859B2 (ja) * 2014-10-17 2020-09-16 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ アムホテリシンｂの毒性が低減された誘導体の規模変更可能な合成法
EP3242554A4 (en) * 2015-01-08 2018-06-06 The Board of Trustees of the University of Illionis Concise synthesis of urea derivatives of amphotericin b
EP3929203A1 (en) 2015-04-15 2021-12-29 Sfunga Therapeutics, Inc. Derivatives of amphotericin b
WO2017100171A1 (en) * 2015-12-08 2017-06-15 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2018106571A1 (en) * 2016-12-06 2018-06-14 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2020051465A1 (en) * 2018-09-07 2020-03-12 The Board Of Trustees Of The University Of Illinois Hybrid amphotericin b derivatives with reduced toxicity
CA3190997A1 (en) * 2020-08-10 2022-02-17 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin b
CN111909226A (zh) * 2020-08-11 2020-11-10 深圳市儿童医院 一种葡萄糖酸修饰的两性霉素b衍生物及其用途
CN115536716A (zh) * 2021-06-29 2022-12-30 中国科学院上海药物研究所 两性霉素b半合成衍生物及其制备方法和用途
CN113773355B (zh) * 2021-08-23 2023-03-10 湖南省微生物研究院 一种多烯大环内酯类化合物及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122086B1 (en) 1979-04-09 1982-06-30 Politechnika Gdanska Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh
ZA807892B (en) 1979-12-24 1981-12-30 Dumex Ltd As Water soluble guanidine derivatives of polyene marcrolides and the esters thereof
JPS56123794A (en) * 1980-02-29 1981-09-29 Nippon Denso Co Ltd Load driving unit for vehicle
JPH024295A (ja) * 1988-06-22 1990-01-09 Toshiba Corp 医用画像診断装置
GB8829593D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
FR2654339B1 (fr) 1989-11-14 1994-10-28 Mayoly Spindler Laboratoires Nouveaux derives solubles et non toxiques des macrolides polyeniques basiques, leur preparation et leurs applications.
FR2683723B1 (fr) * 1991-11-14 1995-05-19 Mayoly Spindler Laboratoires Nouveaux medicaments antiviraux actifs sur le virus vih.
WO1993016090A1 (en) * 1992-02-12 1993-08-19 Smithkline Beecham Plc Amphotericin b derivative
GB9203476D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel compounds
US5606038A (en) 1995-04-10 1997-02-25 Competitive Technologies, Inc. Amphiphilic polyene macrolide antibiotic compounds
PL180253B1 (pl) 1995-05-13 2001-01-31 Politechnika Gdanska Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL
FR2776927B1 (fr) 1998-04-07 2002-07-05 Univ Paris Curie Compositions pour la vectorisation de molecules
AU6397100A (en) 1999-08-02 2001-02-19 Glaxo Group Limited Computer-implemented methods and systems for estimating costs and benefits associated with disease management interventions
CA2394833A1 (en) 2000-01-14 2001-07-19 Binh T. Dang Derivatives of polyene macrolides and preparation and use thereof
US20090186838A1 (en) * 2006-02-23 2009-07-23 Eidgenössische Technische Hochschule Zürich Amphotericin Derivatives
JP2010534688A (ja) 2007-07-30 2010-11-11 上海医薬工業研究院 ポリエン類抗生物質ジエステル化合物
MX365184B (es) 2010-12-21 2019-05-21 Centro De Investig Y De Estudios Avanzados Del I P N Nuevos compuestos analogos de la anfotericina y composiciones farmaceuticas que los contienen.
RU2014152459A (ru) * 2012-06-15 2016-08-10 Блирт С.А. N-замещенные производные второго поколения противогрибкового антибиотика амфотерицина в и способы их получения и применения
AU2014332214B2 (en) * 2013-10-07 2019-10-03 The Board Of Trustees Of The University Of Illinois Amphotericin B derivatives with improved therapeutic index
WO2016112243A1 (en) * 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Urea derivatives of amphotericin b derived from secondary amines
EP3929203A1 (en) 2015-04-15 2021-12-29 Sfunga Therapeutics, Inc. Derivatives of amphotericin b

Also Published As

Publication number Publication date
US20190135847A1 (en) 2019-05-09
TWI702223B (zh) 2020-08-21
KR102106765B1 (ko) 2020-05-06
EP3156410A1 (en) 2017-04-19
AU2015272398B2 (en) 2018-04-26
BR112016028890A8 (pt) 2021-03-23
AU2015272398A1 (en) 2016-12-08
MX2016015455A (es) 2017-03-23
JP6601818B2 (ja) 2019-11-06
CN106414473A (zh) 2017-02-15
EP3156410A4 (en) 2018-01-03
TW201625655A (zh) 2016-07-16
CA2951516C (en) 2019-04-02
IL249430A0 (en) 2017-02-28
US10246478B2 (en) 2019-04-02
EA201692508A1 (ru) 2017-04-28
IL249430B (en) 2020-05-31
US10696707B2 (en) 2020-06-30
KR20170016957A (ko) 2017-02-14
JPWO2015190587A1 (ja) 2017-04-20
CN106414473B (zh) 2020-03-13
WO2015190587A1 (ja) 2015-12-17
EA037093B1 (ru) 2021-02-04
US20170190729A1 (en) 2017-07-06
MA39568A1 (fr) 2017-09-29
CA2951516A1 (en) 2015-12-17
PH12016502357A1 (en) 2017-02-13
SG11201610162XA (en) 2017-01-27

Similar Documents

Publication Publication Date Title
BR112016028890A2 (pt) derivado de macrolídeo de polieno
BR112018010118A2 (pt) inibidores de cxcr2
CL2016000924A1 (es) Mezclas activas como insecticidas, que comprenden un compuesto de carboxamida
ES2791306T8 (es) Cortinas de confinamiento, así como sistemas y aparatos que incluyen las mismas
KR20180084980A (ko) 진단 장치, 컴퓨터 프로그램, 및 진단 시스템
BR112017028318A2 (pt) compostos antibacterianos
BR302013003677S1 (pt) Configuração aplicada em máquina de estereolitografia.
BR112016005966A2 (pt) complexo contendo oligonucleotídeo que tem atividade imunopotenciadora e uso do mesmo
BR302014001648S1 (pt) Configuração aplicada em artigo de fumo
UY34799A (es) ?Evento de maíz MON 87411, plantas, semillas que lo comprenden, polinucleótidos para detectarlo, y métodos relacionados con dicho evento.?
GB201404410D0 (en) Instruction emulation and processors, methods, and systems
DK3250586T3 (da) Hidtil ukendte proteiner, som er specifikke for angiogenese
GB2513975B (en) Instruction emulation processors, methods, and systems
DK3058833T3 (da) Kompleks carbohydratformulering til foder, foder omfattende denne, og anvendelse
BR112017018834A2 (pt) variantes de protoxina-ii e métodos de uso
BR112017020896A2 (pt) variantes de protoxina-ii e métodos de uso
BR112016007062A2 (pt) variantes de protoxina-ii e métodos de uso
FI20135301A (fi) Menetelmä, järjestelmä ja mineraalimateriaalin prosessointilaitos
FR3003713B1 (fr) Signature de groupe utilisant un pseudonyme
CL2015003713A1 (es) Composición herbicida que tiene mejorada seguridad en plantas
HK1223469A1 (zh) 地理、區段、唯分布式計算系統
CL2015002080A1 (es) Métodos de control selectivo de malezas
BR112018011097A2 (pt) beta-glicosidase e usos da mesma
BR112017003148A2 (pt) processo aperfeiçoado para a preparação de lacosamida e seu intermediário inovador
BR112017028361A2 (pt) 2,4,7-trimetiloct-6-en-1-ol como ingrediente de fragrância

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2674 DE 05-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.